Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.
about
Progress on the development of therapeutics against West Nile virusA review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infectionsRapid transport of large polymeric nanoparticles in fresh undiluted human mucus.Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces.Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model.Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis.Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsisEfficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia.Administration of antibody to the lung protects mice against pneumonic plague.Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection.Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces.Controlled-release and local delivery of therapeutic antibodies.Swift antibodies to counter emerging viruses.Development of effective therapies against West Nile virus infection.Antibody therapeutics for Ebola virus disease.Multi-faceted functions of secretory IgA at mucosal surfaces.Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice.Reduction of enterotoxin induced fluid accumulation in ileal loops of neonatal calves with anti-F5 fimbriae recombinant antibody.Could the GI tract be a better portal for antibody therapy?Gut mucosa in HIV infection: "immune milk" solution.The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding.
P2860
Q27489893-CDB96AF0-B80A-4722-A9DE-BC209E1C200EQ30369008-AADA37FC-7C68-4168-8C34-E5F5511AC3FFQ30478934-738AEA1C-7900-4464-ACF5-C150780C7F91Q33347255-9E1FA611-BBDE-45FF-925F-57878959CAB5Q33981259-7F478E7F-3E78-4567-AC01-6B96153C4F63Q34004213-554A64B8-797B-4B9D-A9D8-9C2DCE7209D8Q34006764-680D8BB6-8A36-431E-B23C-A2B942BD5B9EQ34105139-24BAD65F-6B5D-4215-95BF-37AA0D5B66BDQ34119407-AE17B666-1EDB-4981-84AD-AFA9894E7502Q34601788-179E962D-B807-4721-89E2-2E8F4C152CF3Q34991116-E89C7BE5-7A88-42EA-9308-74FDCB4D916CQ35042478-D8BA442C-6CC3-4BCB-85E9-E6811F34A291Q35842644-8CC3C720-E4F7-4A7E-8087-47700C6DB828Q35989719-71BA98A1-0FF3-4B37-A505-E7741D0F1246Q36322125-AD8190B1-BC39-4A35-93E2-97E881802997Q36994087-29F659F4-C576-424C-AE23-19D4F8B1510CQ38123163-D5A70A85-A070-4BDA-997F-86BF95A4DB41Q40344535-90B8CE7E-02F7-4E4A-9ECB-D7EA31B40E81Q40928682-6439EC92-212F-45B0-98A2-61FC24FA3C07Q42836033-F6849D0A-AF58-4745-9499-415B24642492Q42942614-274C7869-C803-45E5-B77E-DE6B82857E41Q47555346-064E861C-C84B-4A62-A607-8455D527EAB6
P2860
Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Using monoclonal antibodies to ...... epidemic infectious diseases.
@ast
Using monoclonal antibodies to ...... epidemic infectious diseases.
@en
Using monoclonal antibodies to ...... epidemic infectious diseases.
@nl
type
label
Using monoclonal antibodies to ...... epidemic infectious diseases.
@ast
Using monoclonal antibodies to ...... epidemic infectious diseases.
@en
Using monoclonal antibodies to ...... epidemic infectious diseases.
@nl
prefLabel
Using monoclonal antibodies to ...... epidemic infectious diseases.
@ast
Using monoclonal antibodies to ...... epidemic infectious diseases.
@en
Using monoclonal antibodies to ...... epidemic infectious diseases.
@nl
P2093
P2860
P921
P356
P1476
Using monoclonal antibodies to ...... epidemic infectious diseases.
@en
P2093
P2860
P356
10.3201/EID0501.990107
P577
1999-01-01T00:00:00Z